Newsroom

Sorted by: Latest

-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Equity Release Funding No 3   GBP 42,000,000.00   MATURING: 26-Apr-2038   ISIN: XS0169951000     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 27-Apr-2026 TO 27-Jul-2026 HAS BEEN FIXED AT 5.27 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 27-Jul-2026 WILL AMOUNT TO: GBP 18.37 PER GBP 1,000.00 DENOMINATION  ...
-

Conti Federal Makes History with the US Army’s First OTA FORGE Contract

TACOMA, Wash.--(BUSINESS WIRE)--Conti Federal Services, LLC, a leading federal construction and design-build firm, has been awarded the first contract of its kind by the Mission and Installation Contracting Command (MICC) using the new Other Transaction Authority (OTA) for military facility construction and repair, securing a $169.1M firm-fixed price contract to execute the FORGE (Facilities, Operations, Readiness, Growth and Experience) Facilities Modernization Program at Joint Base Lewis-McCh...
-

Europäische Kommission genehmigt Crysvita® (burosumab) für Säuglinge mit X-chromosomaler Hypophosphatämie in der Europäischen Union

GALASHIELS, Schottland & MARLOW, England--(BUSINESS WIRE)--Kyowa Kirin EMEA, eine hundertprozentige Tochtergesellschaft der Kyowa Kirin Co., Ltd. (TSE:4151), gab heute bekannt, dass die Europäische Kommission (EK) eine Erweiterung der Indikation für Crysvita® (burosumab) zur Behandlung der X-chromosomalen Hypophosphatämie (XLH) auf Säuglinge im Alter von 1 Monat bis 1 Jahr in der gesamten Europäischen Union und im Europäischen Wirtschaftsraum genehmigt hat. Die Zulassung stellt einen wichtigen...
-

La Commission européenne approuve Crysvita® (burosumab) pour les nourrissons atteints d’hypophosphatémie liée au chromosome X dans l’Union européenne

GALASHIELS, Écosse et MARLOW, Angleterre--(BUSINESS WIRE)--Kyowa Kirin EMEA, filiale à 100 % de Kyowa Kirin Co., Ltd. (TSE : 4151), a annoncé aujourd’hui que la Commission européenne (CE) avait approuvé l’extension de l’indication de Crysvita® (burosumab) pour le traitement de l’hypophosphatémie liée au chromosome X (XLH), afin d’inclure les nourrissons âgés de 1 mois à 1 an dans l’ensemble de l’Union européenne et de l’Espace économique européen. Cette autorisation représente une avancée impor...
-

Tema Launches Healthcare AI ETF (HLTH)

NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), a leader in institutional-quality and actively managed exchange-traded funds, today announced the launch of the Tema Healthcare AI ETF (HLTH). HLTH was developed to invest in one of AI’s largest and most consequential applications: improving healthcare. U.S. healthcare spending is forecast to approach $9 trillion by 2034, representing more than 20% of GDP.1 Yet healthcare accounted for just 8.9% of the S&P 500 as of June 30,2 leaving AI’s poten...
-

S&P Affirms Assured Guaranty’s AA Financial Strength Ratings With Stable Outlook

HAMILTON, Bermuda--(BUSINESS WIRE)--Assured Guaranty Ltd. (NYSE: AGO) (AGL, and together with its subsidiaries, Assured Guaranty) announced today that S&P Global Ratings (S&P) has affirmed the AA financial strength, financial enhancement, and issuer credit ratings of Assured Guaranty’s insurance subsidiaries and the A issuer credit rating of AGL. The outlooks remain stable.In its July 17, 2026 report, S&P highlighted Assured Guaranty’s:“capital and earnings as excellent”“capital adeq...
-

OptiTrack Launches ActiveIO, the Next Generation of Active Tracking with Two-Way Device Communication

CORVALLIS, Ore.--(BUSINESS WIRE)--OptiTrack, the global leader in precision motion capture, today announced the launch of ActiveIO, its next-generation active tracking hardware ecosystem. Built for resilience, precision, and operations that scale, ActiveIO represents the new peak of active marker tracking technology — designed for environments where reliability isn’t optional and operations can’t fail. The system’s breakthrough is a proprietary two-way RF communication protocol that lets OptiTr...
-

Anova Expands Platform With Launch of Next-Generation eTMF Solution for Sponsors, CROs, and Research Sites

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a leading technology-enabled Clinical Research Organization (CRO) focused on accelerating and reducing the cost of clinical development, today announced the launch of its next-generation electronic Trial Master File (eTMF) platform — a unified study document management solution designed to eliminate redundant tasks and administrative burden, improve compliance, and create frictionless collaboration between sponsors, CROs, and r...
-

Venerable and Guardian Reach Agreement to Transition Assets to Venerable’s Investment Advisory Platform

WEST CHESTER, Pa.--(BUSINESS WIRE)--Venerable Holdings, Inc. (“Venerable”), today announced that it has reached an agreement with The Guardian Life Insurance Company of America (“Guardian”) to transition approximately $4.5bn in separate account assets currently held in Guardian’s variable products trust into mutual funds advised by SunAmerica Asset Management, LLC (“SAAMCo”), a Venerable subsidiary. Under the proposed structure, the in-scope funds will be reorganized into a variable insurance m...
-

TP ICAP Midcap initie la couverture de l’action SergeFerrari Group à l’achat

SAINT-JEAN-DE-SOUDAIN, France--(BUSINESS WIRE)--Regulatory News: SergeFerrari Group (FR0011950682 – ALFER), l’un des leaders mondiaux dans les toiles composites innovantes, coté sur Euronext Growth Paris, annonce aujourd’hui l’initiation de la couverture de son titre par TP ICAP Midcap. Dans son étude d’initiation intitulée « Continue de déployer sa toile », TP ICAP Midcap, société de bourse et banque d’affaires spécialisée dans les Small & Mid Caps, entame le suivi de SergeFerrari Group av...